Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

An Eight-week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Generalized Anxiety Disorder

This study has been completed.
Information provided by (Responsible Party):
Sanofi Identifier:
First received: September 7, 2006
Last updated: April 26, 2016
Last verified: April 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2008
  Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: April 26, 2016